These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25266013)
21. The molecular basis of carcinogenesis in Barrett's esophagus. Souza RF J Gastrointest Surg; 2010 Jun; 14(6):937-40. PubMed ID: 20094816 [No Abstract] [Full Text] [Related]
22. Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma. Wang XW; Gao HJ; Fang DC J Dig Dis; 2008 May; 9(2):68-71. PubMed ID: 18419638 [TBL] [Abstract][Full Text] [Related]
23. Family History of Colorectal or Esophageal Cancer in Barrett's Esophagus and Potentially Explanatory Genetic Variants. Rubenstein JH; Tavakkoli A; Koeppe E; Ulintz P; Inadomi JM; Morgenstern H; Appelman H; Scheiman JM; Schoenfeld P; Metko V; Stoffel EM Clin Transl Gastroenterol; 2020 Apr; 11(4):e00151. PubMed ID: 32251017 [TBL] [Abstract][Full Text] [Related]
24. APC gene alterations in Barrett's metaplasia are implicated at an early stage in the carcinogenesis of esophageal adenocarcinoma. Fein M Am J Gastroenterol; 1997 Feb; 92(2):359-60. PubMed ID: 9040229 [No Abstract] [Full Text] [Related]
25. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling. Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019 [TBL] [Abstract][Full Text] [Related]
26. Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus. Li X; Paulson TG; Galipeau PC; Sanchez CA; Liu K; Kuhner MK; Maley CC; Self SG; Vaughan TL; Reid BJ; Blount PL Cancer Prev Res (Phila); 2015 Sep; 8(9):845-56. PubMed ID: 26130253 [TBL] [Abstract][Full Text] [Related]
27. Natural selection in neoplastic progression of Barrett's esophagus. Maley CC; Reid BJ Semin Cancer Biol; 2005 Dec; 15(6):474-83. PubMed ID: 16043360 [TBL] [Abstract][Full Text] [Related]
28. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma. Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246 [No Abstract] [Full Text] [Related]
29. The molecular changes driving the carcinogenesis in Barrett's esophagus: which came first, the chicken or the egg? Russo A; Bronte G; Cabibi D; Bazan V; Cicero G; Bertani A; Rizzo S; Fiorentino E Crit Rev Oncol Hematol; 2013 Jun; 86(3):278-89. PubMed ID: 23290822 [TBL] [Abstract][Full Text] [Related]
30. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence. Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE Genes Chromosomes Cancer; 1998 Jan; 21(1):49-60. PubMed ID: 9443041 [TBL] [Abstract][Full Text] [Related]
31. p27 and Barrett's esophagus: a review*. Ellis FH; Loda M Dis Esophagus; 2004; 17(2):113-7. PubMed ID: 15230722 [TBL] [Abstract][Full Text] [Related]
32. Genetic diversity during the development of Barrett's oesophagus-associated adenocarcinoma: how, when and why? Graham TA; McDonald SA Biochem Soc Trans; 2010 Apr; 38(2):374-9. PubMed ID: 20298186 [TBL] [Abstract][Full Text] [Related]
34. Early Barrett's carcinoma of the esophagus. Hölscher AH; Vallböhmer D; Bollschweiler E Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920 [No Abstract] [Full Text] [Related]
35. The use of imaging and biomarkers in diagnosing Barrett's esophagus and predicting the risk of neoplastic progression. Ramzan Z; Nassri AB; Huerta S Expert Rev Mol Diagn; 2014 Jun; 14(5):575-91. PubMed ID: 24831686 [TBL] [Abstract][Full Text] [Related]
36. Risk prediction in Barrett's esophagus - aspects of a combination of molecular and epidemiologic biomarkers reflecting alterations of the microenvironment. Brandtner AK; Quante M Scand J Clin Lab Invest Suppl; 2016; 245():S63-9. PubMed ID: 27467504 [TBL] [Abstract][Full Text] [Related]
37. Inflammation and Barrett's carcinogenesis. Poehlmann A; Kuester D; Malfertheiner P; Guenther T; Roessner A Pathol Res Pract; 2012 May; 208(5):269-80. PubMed ID: 22541897 [TBL] [Abstract][Full Text] [Related]
38. Endoscopy for diagnosis and treatment in esophageal cancers: high-technology assessment. Akiyama J; Komanduri S; Konda VJ; Mashimo H; Noria S; Triadafilopoulos G Ann N Y Acad Sci; 2014 Sep; 1325():77-88. PubMed ID: 25266017 [TBL] [Abstract][Full Text] [Related]
39. Barrett's esophagus and esophageal cancer: an overview. Conteduca V; Sansonno D; Ingravallo G; Marangi S; Russi S; Lauletta G; Dammacco F Int J Oncol; 2012 Aug; 41(2):414-24. PubMed ID: 22615011 [TBL] [Abstract][Full Text] [Related]
40. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]